NCT02830698

Brief Summary

Abdominal pain disorders functional (including functional dyspepsia, irritable bowel syndrome, abdominal migraine, functional abdominal pain) is a very common disease in the pediatric population, where classical medical treatment does not always prove effective. This clinical entity has an impact on the individual physiological balance particularly on the autonomic regulation. Studies concerning adults with irritable bowel syndrome, showed significant changes in heart rate variability indices (HRV: heart rate variability). The study of time and frequency domain analysis of HRV allows noninvasive and reproducible assessment of the cardiac sympathetic and parasympathetic tone. The investigators hypothesize that the sympathovagal balance could be altered in children in case of prolonged nociceptive stress as the investigators find it especially in irritable bowel syndrome and functional abdominal pain. In recent years, the control of pediatric pain experienced considerable growth through hypnosis techniques and several studies have shown analgesic efficacy with a beneficial effect in terms of quality of life in children. Our study aims to assess the impact of the hypno-analgesia treatment of Abdominal pain disorders functional on sympathovagal balance. The investigators propose to realize in 7 to 18 years old children with Abdominal pain disorders functional a single center prospective study to highlight after a standardized hypnosis program, changes in the time and frequency domain indices of heart rate variability and clinical or quality of life parameters. The primary endpoint will be the high frequency HF indice. Secondary endpoints will be the other indices of HRV (Ptot, VLF, LF, ratio LF / HF, SDNN, SDANN, pNN50, RMSSD), the Quality of Life Questionnaire values (PedsQL ™ 4.0) a pain scale and the composite score of Francis.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2017

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 21, 2016

Completed
22 days until next milestone

First Posted

Study publicly available on registry

July 13, 2016

Completed
11 months until next milestone

Study Start

First participant enrolled

May 31, 2017

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2019

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 29, 2019

Completed
Last Updated

November 7, 2022

Status Verified

November 1, 2022

Enrollment Period

1.7 years

First QC Date

June 21, 2016

Last Update Submit

November 2, 2022

Conditions

Keywords

Nervous SystemHypnosisElectrocardiography, AmbulatoryAbdominal pain disorders functional

Outcome Measures

Primary Outcomes (1)

  • high frequency

    measured with the holter

    One month after the hypno-analgesic therapeutic program

Secondary Outcomes (13)

  • composite score of Francis

    One month after the hypno-analgesic therapeutic program

  • Pediatric Quality of Life inventory

    One month after the hypno-analgesic therapeutic program

  • a chronic abdominal pain scale

    One month after the hypno-analgesic therapeutic program

  • a severity of functional dyspepsia scale

    One month after the hypno-analgesic therapeutic program

  • a severity of abdominal migraine scale

    One month after the hypno-analgesic therapeutic program

  • +8 more secondary outcomes

Eligibility Criteria

Age7 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Indices of autonomic nervous system in a pediatric population with Abdominal pain disorders functional

You may qualify if:

  • Parents affiliates or entitled to a social security scheme
  • Consent form signed by the holder of parental authority

You may not qualify if:

  • Child with pathologies reaching the central nervous system or the brain stem.
  • Children with a severe pathology of cardio-respiratory or heart being referred to treatment.
  • Children requiring emergency surgery or trauma or septic or inflammatory context.
  • Children with psychiatric disorders or mental retardation proven.
  • Children who have already used the earlier hypnosis.
  • Children not speaking French language.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Universitaire de Saint Etienne

Saint-Etienne, 42055, France

Location

MeSH Terms

Conditions

Abdominal PainNeurologic Manifestations

Condition Hierarchy (Ancestors)

PainSigns and SymptomsPathological Conditions, Signs and SymptomsSigns and Symptoms, DigestiveNervous System Diseases

Study Officials

  • Hugues PATURAL, MD PhD

    Centre Hospitalier Universitaire de Saint Etienne

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 21, 2016

First Posted

July 13, 2016

Study Start

May 31, 2017

Primary Completion

January 31, 2019

Study Completion

May 29, 2019

Last Updated

November 7, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations